Quick Answer
Caris Life Sciences, Inc. reported Shares Outstanding of 282.53 million shares for fiscal year 2025.
Caris Life Sciences, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 282.53M | +674.0% |
| 2024 | 36.50M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 282.10M | — | +0.4% |
| June 30, 2025 | 281.09M | — | +670.0% |
| December 31, 2024 | 36.50M | — | — |
- Caris Life Sciences, Inc. showed an increase of +674.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2024–2025 period, Caris Life Sciences, Inc.’s shares outstanding has grown by 674.0% (from 36.50 million shares to 282.53 million shares).
- The most recent figure is from Caris Life Sciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: